Dick Simon, Sensorium Therapeutics CEO
Mining from plants and fungi, CNS startup takes leap into psychoactive drugs — complete with $30M to kick things off
A biotech with founders out of Mass General and Harvard is looking to take the next step in the mental health and CNS space, and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
